Back | Next |
home / stock / mbrx / mbrx message board
Subject | By | Source | When |
---|---|---|---|
I cant believe that this message board has | TheSprinx | investorshub | 02/16/2021 2:22:23 AM |
Annamycin is a next-generation anthracycline that has recently | Chemist823 | investorshub | 02/14/2021 4:28:26 PM |
chemist823: Looks like a triple waiting to happen. 100% success rate with cancer drug not to mention | chemist823 | investorshangout | 02/11/2021 8:46:49 PM |
This looks to me to be severely under priced. | Chemist823 | investorshub | 02/11/2021 8:44:07 PM |
whytestocks: $MBRX News Article - Moleculin Announces Full Exercise of Over-Allotment Option | whytestocks | investorshangout | 02/10/2021 9:35:50 PM |
5.70!!!!! | TheSprinx | investorshub | 02/10/2021 12:18:29 PM |
Make it 5.18!!! Lol | TheSprinx | investorshub | 02/09/2021 10:45:02 PM |
Check that $5.15!! | TheSprinx | investorshub | 02/09/2021 9:53:37 PM |
$5.10!! News Eminent | TheSprinx | investorshub | 02/09/2021 8:28:43 PM |
It was there confirmation that they closed. Share | TheSprinx | investorshub | 02/09/2021 7:32:19 PM |
Prolly another R/S | tigertiger88 | investorshub | 02/08/2021 9:39:44 PM |
I smell something great about to Happen! | TheSprinx | investorshub | 02/08/2021 8:34:30 PM |
Sold my shares and deleted from my watchlist | Wolf91 | investorshub | 02/04/2021 2:36:51 PM |
Offering at $4.75. Closes Friday. Time to load | TheSprinx | investorshub | 02/03/2021 7:24:24 PM |
rinse, repeat | tigertiger88 | investorshub | 02/03/2021 3:42:25 PM |
Not looking good today. | Dennisb68 | investorshub | 02/03/2021 2:17:51 PM |
Selling off in AH trading. Down 1/2 of | Dennisb68 | investorshub | 02/03/2021 12:05:56 AM |
* * $MBRX Video Chart 02-02-2021 * * | ClayTrader | investorshub | 02/02/2021 10:59:27 PM |
I sold out right after Waiting for this to | TheSprinx | investorshub | 02/02/2021 9:41:17 PM |
znewcar1: MBRX 35% v53,8M c6.39 f10,4M preMH9.3 S6.77 then ran to HOD8.78 only to fail down | znewcar1 | investorshangout | 02/02/2021 9:38:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON , May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage ...
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06) PR Newswire – Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin ...
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire – Recently announced interim data from ongoing MB-106 study demonstrating Annamycin in combination with Cytarabine (AnnAraC) achieves CRc rate of 62% (54% CR) in 1 st an...